# US Organ Preservation Market > US Organ Preservation Market Research Report By Solution (University of Wisconsin Solution, Custodial HTK, Collins Solution, Celsior Solution, Perfadex, Citrate Solution), By Preservation Techniques (Static Cold Storage, Dynamic Cold Storage), By Organ Type (Kidney, Liver, Heart, Lungs) and By End User (Hospitals & Clinics, Organ Banks) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.33% - **2024:** $ 82.7 Million - **2025:** $ 88.76 Million - **2035:** $ 180 Million - **Key Players:** Organ Recovery Systems (US), TransMedics (US), Xvivo Perfusion (SE), LifeLink Foundation (US), Tissue Regenix (GB), Paragonix Technologies (US), Bridge to Life (US), Preservation Solutions (US) **Report ID:** MRFR/MED/47702-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-organ-preservation-market-49453 --- ## Market Summary ## **US Organ Preservation Market Overview** As per MRFR analysis, the US Organ Preservation Market Size was estimated at 78.72 (USD Million) in 2023. The US Organ Preservation Market Industry is expected to grow from 85(USD Million) in 2024 to 158 (USD Million) by 2035. The US Organ Preservation Market CAGR (growth rate) is expected to be around 5.798% during the forecast period (2025 - 2035). ### **Key US Organ Preservation Market Trends Highlighted** The US Organ Preservation Market is experiencing significant trends driven by advancements in medical technology and increasing demand for organ transplantation. A key market driver is the rising prevalence of chronic diseases, which leads to a higher need for organ transplants. The aging population in the US further exacerbates this demand, as older individuals are more likely to require organ replacement due to organ failures. Additionally, regulatory support from institutions such as the US Department of Health and Human Services encourages research and development in organ preservation techniques, thereby promoting growth in the market. Opportunities in the US Organ Preservation Market include the development of innovative preservation solutions that enhance organ viability and reduce transplantation failures.Improved methods such as normothermic machine perfusion and advanced cold storage techniques are being actively explored. These technologies not only promise better outcomes for transplant patients but also extend the preservation time for organs, making more efficient use of available organs. In recent times, there has been a notable trend toward using organ preservation techniques in multi-organ transplants, which can improve transplant success rates. Furthermore, the ethical considerations around organ donation and transplantation are evolving, with increased public awareness leading to more individuals signing up for organ donation. Collaborative efforts between healthcare providers, non-profit organizations, and governmental bodies are essential for educating the public and promoting donor registrations.Overall, these trends signify a dynamic and responsive market in response to the urgent need for effective organ preservation solutions in the US. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ## **US Organ Preservation Market Drivers** ### **Increasing Number of Organ Transplants** The growing number of organ transplants carried out each year is fueling development in the US organ preservation market. Over 39,000 organ transplants were carried out in the US in 2022, according to the United Network for Organ Sharing (UNOS), a figure that has steadily risen over the previous 10 years. An older population and improvements in medical technology are the main causes of this increase in transplant procedures. Given that 40% of receivers are 50 years of age or older, the need for organ preservation technologies is expected to rise as the population ages. The US organ preservation market industry is indirectly boosted by organizations like the National Institutes of Health (NIH), which have played a key role in research projects aimed at increasing organ transplant success rates. ### **Technological Advancements in Preservation Methods** The US Organ Preservation Market Industry is benefitting from significant technological advancements in organ preservation methods. Innovative solutions such as Machine Perfusion, which helps maintain organ function during transportation, are gaining traction. The American Society of Transplant Surgeons (ASTS) reports that machine perfusion can enhance organ viability and improve transplant outcomes, particularly for kidneys and livers. As a result, hospitals and transplant centers are increasingly adopting these technologies, leading to a corresponding rise in the demand for organ preservation products and services. ### **Growing Public Awareness and Donation Drives** Public awareness about the importance of organ donation has spurred a significant increase in donor registrations across the United States. According to data from the Health Resources and Services Administration (HRSA), the national organ donor registry saw a surge of over 12 million new registrants in 2021 alone. Campaigns and initiatives led by organizations such as Donate Life America have effectively educated the public about organ donation's life-saving potential, which translates into a higher volume of organs available for transplantation and, subsequently, a greater need for effective organ preservation techniques in the US Organ Preservation Market Industry. ### **Regulatory Support for Organ Preservation Initiatives** Regulatory measures and incentives promoting organ donation and preservation are contributing positively to the US Organ Preservation Market Industry. The recent Advancing American Kidney Health initiative introduced by the U.S. Department of Health and Human Services aims to increase the number of kidney transplants and improve preservation techniques. This government-sponsored program can be seen as a response to the growing waitlist for organ transplants in the U.S.Census Bureau indicates that about 100,000 individuals are currently on the transplant waiting list. By prioritizing organ preservation and enhancing the infrastructure around organ donation, these regulatory frameworks are fostering an environment ripe for market growth. ## **US Organ Preservation Market Segment Insights** ### **Organ Preservation Market Solution Insights** The US Organ Preservation Market has been experiencing substantial growth, particularly within the Solution segment, which is pivotal in enhancing the viability of organs for transplantation. This segment plays a critical role in ensuring that organs remain functional during the transportation process, significantly impacting transplant outcomes. Among the various solutions utilized, the University of Wisconsin Solution is acclaimed for its efficacy in preserving kidneys and other solid organs, making it a preferred choice among medical professionals. Another notable solution is Custodial HTK, which has been specifically designed to preserve organs by maintaining their physiological processes during the cold storage period. As a result, it is widely accepted for use in liver and heart transplants. Collins Solution is also significant, particularly for liver transplants, as it is formulated to provide optimal conditions for organ preservation, thus improving the survival rates post-transplant. The Celsior Solution, known for its unique composition, offers considerable benefits to the preservation of pancreatic and renal tissues, facilitating better outcomes in transplantation procedures. Perfadex is a specialized solution primarily for lung preservation, which has gained prominence due to its effectiveness in prolonging the organ's functional state. Citrate Solution is primarily used in vascular graft preservation, playing a crucial role in maintaining the longevity of these critical tissues. Current trends indicate that the choice of preservation solution can significantly influence the efficiency of organ transplant operations and, consequently, the overall patient survival rates. The growth drivers for this market segment include an increasing number of organ transplant procedures and advancements in preservation technologies, which provide opportunities for innovation and market expansion. Additionally, as the US healthcare system increasingly focuses on improving transplant success rates, the demand for robust preservation solutions remains strong, illustrating the importance of this segment in the larger context of the US Organ Preservation Market. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ### **Organ Preservation Market Preservation Techniques Insights** The Preservation Techniques segment within the US Organ Preservation Market plays a critical role in ensuring the viability of organs for transplantation. This segment primarily includes Static Cold Storage and Dynamic Cold Storage, both of which are essential methods used to extend the life of harvested organs. Static Cold Storage is a widely adopted technique that offers simplicity and cost-effectiveness, making it a popular choice among hospitals. On the other hand, Dynamic Cold Storage is gaining traction due to its ability to optimize organ function during preservation, thereby enhancing transplantation success rates.The increasing number of organ transplant surgeries, driven by rising incidences of organ failure in the US, underscores the importance of effective preservation techniques. Furthermore, advancements in technology are creating opportunities for improved storage solutions that can enhance organ preservation and reduce wastage, thereby illustrating the market's growth potential. Overall, these preservation techniques are crucial in improving patient outcomes and increasing the efficiency of organ transplant processes in the US. ### **Organ Preservation Market Organ Type Insights** The US Organ Preservation Market exhibits considerable segmentation by organ type, encompassing critical categories such as Kidney, Liver, Heart, and Lungs. This market is pivotal to enhancing transplant success rates and improving patient outcomes. The Kidney segment holds a significant position, largely due to the high demand for kidney transplants resulting from chronic kidney diseases, making it a crucial focus for preservation efforts. The Liver segment is similarly vital, as liver diseases remain prevalent and necessitate effective preservation techniques to facilitate successful transplants, thus highlighting its importance within the market.The Heart segment benefits from advances in preservation technology aimed at extending the viability of donor hearts, addressing the growing need for cardiac transplants amid increasing cardiovascular diseases in the US population. Lastly, the Lungs segment accounts for a smaller portion of the market but faces unique challenges, primarily linked to the organ's sensitivity to time and condition during preservation, emphasizing the need for specialized solutions. Collectively, these segments illustrate the diversity and complexity of the US Organ Preservation Market, with significant emphasis placed on improving methodologies to enhance the quality of life for patients in need of organ transplants. ### **Organ Preservation Market End User Insights** The End User segment of the US Organ Preservation Market plays a critical role in the overall infrastructure for organ transplantation. This segment comprises primary stakeholders like Hospitals and Clinics, along with Organ Banks, which are essential for maintaining the integrity and viability of organs for transplantation. Hospitals and Clinics are pivotal as they provide the necessary facilities and specialized healthcare professionals required for organ preservation, ensuring that organs are preserved under optimal conditions before transplantation. Organ Banks, on the other hand, function as collection and storage facilities for donated organs, acting as a central hub in the transplantation process. They are responsible for the evaluation, preservation, and allocation of organs, which is crucial given the pressing need for organ donations in the US. The increasing number of organ transplant procedures coupled with advancements in preservation technologies drives the demand in this segment. However, this market also faces challenges, such as logistical issues and regulatory guidelines that can impact the effectiveness of organ preservation.Overall, this market segment is vital in addressing the healthcare needs of patients requiring organ transplants while also offering opportunities for innovation in preservation methods and technologies. ## **US Organ Preservation Market Key Players and Competitive Insights** The US Organ Preservation Market has seen significant advancements and a competitive edge driven by technological innovation, improved processes, and strategic collaborations. As the demand for organ transplants continues to rise, various players in the market are focusing on enhancing preservation methods to prolong organ viability outside the human body. Research and development efforts have concentrated on developing novel preservation solutions and devices, driving the market forward with solutions that enhance preservation times and overall organ function post-transplant. Additionally, regulatory frameworks and partnerships with transplant centers play a crucial role in shaping the competitive landscape. Companies are continually looking to gain an edge through differentiation in their product offerings and exploring mergers and acquisitions to strengthen their market position. Lifeline Scientific has established a notable presence in the US Organ Preservation Market with a strong focus on innovative organ preservation technologies. The company's strengths lie in its state-of-the-art preservation solutions that significantly enhance organ viability, ensuring better outcomes in transplantation. Lifeline Scientific is known for its proprietary systems that enable optimal organ preservation by minimizing ischemia and maximizing the quality of donated organs. The company's commitment to research and development has solidified its reputation as a key player in the market, allowing it to maintain a competitive advantage. Moreover, Lifeline Scientific has developed strategic partnerships with transplant centers, which helps in the adoption of its innovative technologies across the healthcare landscape in the US. Bellicum Pharmaceuticals, while primarily known for its advancements in cell therapy treatments, also holds a considerable stake in the US Organ Preservation Market. The company offers unique technologies aimed at improving organ preservation through genetically engineered cell therapies that enhance the viability of transplanted organs. Bellicum's strengths include its focus on innovation and ongoing clinical trials that reinforce its commitment to expanding its product portfolio in the organ preservation space. The company's active engagement in mergers and acquisitions has allowed it to integrate complementary technologies into its offerings, thereby bolstering its presence in the US market. This strategic positioning enables Bellicum Pharmaceuticals to leverage its scientific expertise to address the significant challenges associated with organ preservation and create solutions that cater specifically to the needs of the transplant community. ### **Key Companies in the US Organ Preservation Market Include** ## **US Organ Preservation Market Industry Developments** The US Organ Preservation Market has seen significant developments in recent months, with companies like Lifeline Scientific and TransMedics advancing their preservation technologies. In August 2023, Lifeline Scientific announced an expansion in its operations, enhancing its capabilities in organ storage solutions, thus promoting better organ viability for transplantation. Meanwhile, in July 2023, TransMedics received FDA approval for its Organ Care System, which has been pivotal in improving organ preservation for heart transplants. The market is also witnessing competitive growth, with market valuations of companies such as Otsuka Pharmaceutical and Celsior continuing to rise as they further innovate preservation techniques. In terms of mergers and acquisitions, there have been notable activities; for instance, in September 2022, Acelity announced the acquisition of Advanced Biohealing, which has shown promise in enhancing organ preservation methods. The ongoing advancements and competitive acquisitions are reshaping the landscape of organ preservation in the US, indicating a robust market that is evolving to increase the number of successful transplants. Moreover, the importance of bioengineering and perfusion technologies is increasingly gaining attention, reflecting the market's dynamic and growth-oriented nature. ## **US Organ Preservation Market Segmentation Insights** ### **Organ Preservation Market Solution Outlook** ### **Organ Preservation Market Preservation Techniques Outlook** ### **Organ Preservation Market Organ Type Outlook** ### **Organ Preservation Market End User Outlook** ## Market Drivers ### Growing Awareness and Education There is a notable increase in public awareness regarding organ donation and transplantation in the US. Educational campaigns and initiatives by health organizations are playing a crucial role in informing the public about the importance of organ donation. This heightened awareness is likely to lead to an increase in donor registrations, which in turn will boost the organ preservation market. The organ preservation market is expected to benefit from this trend, as more organs become available for transplantation. Reports indicate that states with active educational programs have seen a 15% rise in donor registrations, highlighting the potential impact of awareness on market dynamics. ### Regulatory Framework Enhancements The regulatory environment surrounding organ transplantation and preservation is evolving, with new guidelines being established to ensure the safety and efficacy of organ preservation methods. The US government has been actively working to streamline regulations, which is likely to foster innovation within the organ preservation market. Enhanced regulatory support can lead to increased funding for research and development, as well as improved standards for organ preservation techniques. The organ preservation market stands to gain from these regulatory enhancements, as they may facilitate faster approvals for new technologies, ultimately benefiting patients in need of transplants. ### Rising Incidence of Organ Failure The increasing prevalence of chronic diseases such as diabetes and hypertension in the US is contributing to a higher incidence of organ failure. This trend is likely to drive the organ preservation market as the need for organ transplants escalates. According to recent statistics, approximately 30 million Americans are affected by diabetes, which significantly raises the risk of kidney failure. As the demand for viable organs grows, the organ preservation market is expected to expand, with a projected growth rate of around 8% annually. This surge in organ failure cases necessitates advanced preservation techniques to enhance organ viability during transportation and storage, thereby propelling market growth. ### Advancements in Preservation Technologies Innovations in organ preservation technologies are transforming the landscape of the organ preservation market. Techniques such as machine perfusion and hypothermic preservation are gaining traction, offering improved outcomes for organ viability. For instance, machine perfusion has been shown to extend the preservation time of kidneys from 24 hours to over 48 hours, which is a substantial improvement. The organ preservation market is witnessing investments in research and development, with funding exceeding $200 million in recent years. These advancements not only enhance the success rates of transplants but also increase the efficiency of organ allocation, thereby driving market growth. ### Increased Investment in Healthcare Infrastructure The US healthcare infrastructure is undergoing significant enhancements, with increased investments aimed at improving transplant facilities and organ preservation capabilities. This trend is likely to bolster the organ preservation market, as state-of-the-art facilities are essential for effective organ storage and transportation. Recent reports indicate that healthcare spending in the US is projected to reach $4 trillion by 2025, with a substantial portion allocated to transplant services. The organ preservation market is expected to thrive as healthcare providers adopt advanced preservation technologies and improve their operational efficiencies, ultimately leading to better patient outcomes. ## Future Outlook The [Organ Preservation Market](https://www.marketresearchfuture.com/reports/organ-preservation-market-6073) is projected to grow at a 7.33% CAGR from 2025 to 2035, driven by technological advancements, increasing organ transplant demand, and enhanced preservation techniques. **New opportunities:** - Development of advanced hypothermic preservation solutions for extended organ viability. - Implementation of AI-driven logistics for organ transport optimization. - Expansion of partnerships with hospitals for on-site organ preservation training programs. By 2035, the organ preservation market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Solution: University of Wisconsin Solution (Largest) vs. Custodial HTK (Fastest-Growing) The analysis of the solution segment in the US organ preservation market reveals a diverse landscape characterized by several key products. The University of Wisconsin Solution emerges as the largest player, commanding significant market share due to its established efficacy and widespread acceptance in clinical practices. Following closely, Custodial HTK is gaining traction, supported by its innovative formulation that enhances preservation times, which is crucial in transplantation scenarios. In terms of growth trends, Custodial HTK is noted for its rapid expansion, driven by increasing demand for effective preservation methods amid rising organ transplant procedures. Factors such as advancements in medical technology and the growing awareness of organ donation are propelling the adoption of solutions that extend organ viability, highlighting the dynamic nature of this segment. A competitive landscape is formed as manufacturers innovate to improve their offerings, responding to the evolving needs of healthcare providers. University of Wisconsin Solution (Dominant) vs. Custodial HTK (Emerging) The University of Wisconsin Solution is recognized as a dominant force in the US organ preservation market, praised for its effectiveness in maintaining organ viability for extended periods. Its formulation has become the gold standard for organ preservation, especially in kidney transplants, leading to a reliable reputation among healthcare professionals. Conversely, Custodial HTK is emerging rapidly, showcasing its potential to reshape the market landscape with its unique preservation capabilities. The solution offers advantages like reduced cytotoxicity and improved organ functions post-transplant, appealing to transplant surgeons looking for optimal outcomes. As both solutions vie for attention, their respective strengths highlight the ongoing innovation and competition within the market. ### By Preservation Techniques: Static Cold Storage (Largest) vs. Dynamic Cold Storage (Fastest-Growing) In the US organ preservation market, Static Cold Storage is the largest segment, commanding a significant share due to its widespread acceptance and established protocols. The segment benefits from a long history of use in organ transport and storage, resulting in robust trust among healthcare providers. Dynamic Cold Storage, while smaller, is growing rapidly as advancements in technology and increased research into optimal preservation methods create opportunities for its adoption. The growth of Dynamic Cold Storage is driven by innovation and the need for enhanced preservation techniques that can increase the viability of organs for transplantation. Factors such as a rise in organ transplant procedures and supportive regulatory frameworks are contributing to this trend. As practitioners seek more efficient and effective methods for organ preservation, Dynamic Cold Storage is positioned to capture a greater market share in the coming years. Static Cold Storage (Dominant) vs. Dynamic Cold Storage (Emerging) Static Cold Storage is characterized by its reliability and simplicity, often utilizing ice and specific temperatures to maintain organ viability. Its dominance in the market is attributed to established protocols that have been tested over decades, ensuring safety and effectiveness in organ transportation. Conversely, Dynamic Cold Storage represents an emerging approach that employs more sophisticated technology to maintain organs at optimal temperatures and conditions, potentially extending their preservation time. This method is gaining traction due to its ability to enhance graft function and improve clinical outcomes, making it a compelling choice for a growing number of transplant programs. ### By Organ Type: Kidney (Largest) vs. Liver (Fastest-Growing) The market share distribution among organ types in the US organ preservation market shows that kidneys hold the largest share, significantly overshadowing other organs. Following kidneys, the liver segment is showing promising growth trends, which is expected to enhance its market position in the coming years. The heart and lungs, while crucial, currently represent smaller portions of the market, impacting the overall distribution dynamics. Growth trends in the organ preservation segment are predominantly driven by advancements in preservation technologies and increasing organ transplant rates. The liver segment is emerging as the fastest-growing area due to rising demands for liver transplants and improved preservation methods. Additionally, organ donation awareness and initiatives are fostering overall growth across all organ types, as the requirement for effective preservation solutions continues to rise. Kidney (Dominant) vs. Heart (Emerging) The kidney segment is the dominant player in the organ preservation landscape, largely attributed to its critical role in transplantation and the high prevalence of kidney-related ailments. This dominance is reinforced by established preservation methods and widespread clinical practices. On the other hand, the heart segment is emerging as a vital area with growth potential, driven by increasing awareness and advancements in preservation technologies. Heart transplants, while still relatively less common than kidney transplants, are gaining attention due to improved surgical outcomes and resource allocation. The differentiation in market position between these organ types highlights the need for tailored preservation solutions that cater specifically to the unique challenges presented in preserving each organ. ### By End-User: Hospitals & Clinics (Largest) vs. Organ Banks (Fastest-Growing) In the US organ preservation market, hospitals and clinics represent the largest segment, capturing a significant share due to their critical role in organ transplantation and patient care. They are equipped with advanced technology and infrastructure, facilitating the effective preservation of organs. On the other hand, organ banks are rapidly emerging as a crucial component, gaining popularity for their specialized focus on organ storage and distribution. Their adaptability to new technologies and methods significantly enhances their market presence. Growth trends in the end-user segment are driven by increasing transplantation procedures and the rising need for organ preservation methods. Hospitals and clinics continue to lead, bolstered by advancements in medical technology that improve organ viability, while organ banks are experiencing a surge in demand as collaboration with healthcare facilities intensifies. This competitive landscape signifies a robust expansion for both end-user categories, highlighting the importance of organ preservation solutions in enhancing patient outcomes. Hospitals & Clinics (Dominant) vs. Organ Banks (Emerging) Hospitals and clinics are the dominant players in the US organ preservation market, primarily due to their extensive resources and established protocols for organ transplantation. These facilities are often at the forefront of adopting innovative preservation techniques, ensuring optimized organ viability for transplant procedures. In contrast, organ banks are emerging as vital contributors, focusing exclusively on the storage, preservation, and distribution of organs. Their unique position allows for specialized processes tailored to maintaining organ integrity, making them increasingly essential in the transplantation ecosystem. As partnerships between hospitals and organ banks grow, both segments are positioned for sustained growth, reflecting their respective strengths in the market. ## Competitive Benchmarking The organ preservation market is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for organ transplants. Key players such as Organ Recovery Systems (US), TransMedics (US), and Paragonix Technologies (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. Organ Recovery Systems (US) focuses on innovation in preservation solutions, while TransMedics (US) emphasizes the development of advanced organ perfusion systems. Paragonix Technologies (US) is leveraging partnerships to expand its product offerings, collectively shaping a competitive environment that prioritizes technological superiority and operational efficiency.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance responsiveness to market demands. The competitive structure of the organ preservation market appears moderately fragmented, with several players vying for market share. The collective influence of these key players fosters a competitive atmosphere where innovation and strategic collaborations are paramount. In October TransMedics (US) announced a strategic partnership with a leading transplant center to enhance the clinical application of its Organ Care System. This collaboration is expected to facilitate the adoption of their technology in real-world settings, potentially increasing the number of successful organ transplants. Such partnerships are crucial as they not only validate the technology but also expand the reach of TransMedics' solutions in the market. In September Paragonix Technologies (US) launched a new version of its organ preservation device, which incorporates advanced monitoring capabilities. This innovation is significant as it addresses the critical need for real-time data during organ transport, thereby improving outcomes. The introduction of this device may position Paragonix as a leader in the segment, appealing to healthcare providers seeking reliable preservation solutions. In August Organ Recovery Systems (US) expanded its manufacturing capabilities by investing in a new facility dedicated to the production of preservation solutions. This move is indicative of the company's commitment to meeting growing demand and enhancing supply chain reliability. By increasing production capacity, Organ Recovery Systems aims to solidify its market presence and respond effectively to the needs of transplant centers. As of November current trends in the organ preservation market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) in preservation technologies. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve, with a shift from price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition underscores the importance of developing cutting-edge solutions that not only meet regulatory standards but also enhance patient outcomes. ## Recent News & Developments The US Organ Preservation Market has seen significant developments in recent months, with companies like Lifeline Scientific and TransMedics advancing their preservation technologies. In August 2023, Lifeline Scientific announced an expansion in its operations, enhancing its capabilities in organ storage solutions, thus promoting better organ viability for transplantation. Meanwhile, in July 2023, TransMedics received FDA approval for its Organ Care System, which has been pivotal in improving organ preservation for heart transplants. The market is also witnessing competitive growth, with market valuations of companies such as Otsuka Pharmaceutical and Celsior continuing to rise as they further innovate preservation techniques. In terms of mergers and acquisitions, there have been notable activities; for instance, in September 2022, Acelity announced the acquisition of Advanced Biohealing, which has shown promise in enhancing organ preservation methods. The ongoing advancements and competitive acquisitions are reshaping the landscape of organ preservation in the US, indicating a robust market that is evolving to increase the number of successful transplants. Moreover, the importance of bioengineering and perfusion technologies is increasingly gaining attention, reflecting the market's dynamic and growth-oriented nature. ## Report Scope | MARKET SIZE 2024 | 82.7(USD Million) | | --- | --- | | MARKET SIZE 2025 | 88.76(USD Million) | | MARKET SIZE 2035 | 180.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.33% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Organ Recovery Systems (US), TransMedics (US), Xvivo Perfusion (SE), LifeLink Foundation (US), Tissue Regenix (GB), Paragonix Technologies (US), Bridge to Life (US), Preservation Solutions (US) | | Segments Covered | Solution, Preservation Techniques, Organ Type, End-User | | Key Market Opportunities | Advancements in preservation techniques enhance organ viability, driving demand in the organ preservation market. | | Key Market Dynamics | Technological advancements in preservation methods drive competition and enhance organ viability in transplantation. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the current valuation of the US organ preservation market?** A: The market valuation was $82.7 Million in 2024. **Q: What is the projected market size for the US organ preservation market by 2035?** A: The market is projected to reach $180.0 Million by 2035. **Q: What is the expected CAGR for the US organ preservation market during the forecast period 2025 - 2035?** A: The expected CAGR is 7.33% during the forecast period. **Q: Which companies are considered key players in the US organ preservation market?** A: Key players include Organ Recovery Systems, TransMedics, Xvivo Perfusion, and others. **Q: What are the main segments of the US organ preservation market?** A: The main segments include Solutions, Preservation Techniques, Organ Type, and End-User. **Q: What was the valuation of the University of Wisconsin Solution segment in 2024?** A: The University of Wisconsin Solution segment was valued at $20.0 Million in 2024. **Q: How does the valuation of Static Cold Storage compare to Dynamic Cold Storage?** A: Static Cold Storage was valued at $40.0 Million, while Dynamic Cold Storage was valued at $42.7 Million in 2024. **Q: What is the valuation range for the Kidney organ type segment?** A: The Kidney organ type segment had a valuation range of $20.0 Million to $45.0 Million in 2024. **Q: Which end-users dominate the US organ preservation market?** A: Hospitals & Clinics and Organ Banks are the primary end-users, with valuations of $50.0 Million and $32.7 Million respectively in 2024. **Q: What is the projected growth trend for the US organ preservation market?** A: The market is expected to grow significantly, reaching $180.0 Million by 2035, indicating a robust growth trend. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-organ-preservation-market-49453*